New: NCI-funded clinical trial search
Mednet Logo
CommunityGynecologic Oncology

Would uterine serosal involvement change your adjuvant treatment recommendation for a patient with Stage II grade 2 endometrial cancer?

Tumor traverses the myometrium to focally involve the serosa; 1/6 sentinels with ITC and the rest negative.
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Abramson Cancer Center, University of Pennsylvania
Answered on

Would recommend chemotherapy and vaginal brachytherapy.

Had the patient had Stage II, Grade 2 disease (ignore the ITC for a moment), we would offer the patient pelvic radiation therapy alone based on GOG 249 and PORTEC 3 results, the latter of which showed a benefit of chemotherapy largely driven by IIIC and serous patients. Pelvic radiation for Stage II disease is often accompanied by a vaginal brachytherapy boost, acknowledging boost has not been independently tested in high level fashion.

With...

Join for free or sign in to see the full answer

Mednet MemberInvited Expert
Gynecologic Oncology · UCLA David Geffen School of Medicine/UCLA Medical Center
Answered on

Serosal involvement in endometrial cancer upstages a patient to Stage IIIA. Despite a likely risk of recurrence in the pelvis/vagina for a cancer that involves the cervix, the standard of care for this stage is chemotherapy. Some, however, might include radiation therapy either in a sandwiched approach or before/after chemo is complete. There are several trials exploring these patients but perhaps the most relevant is that published by Matei et al 2020. On this trial of 813 patients randomized t...

Join for free or sign in to see the full answer